Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03429413 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

StatusNot Yet Recruiting
PhaseNot applicable
Started2027-09-15
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Sep 15, 2027 → Sep 15, 2028
See other at-risk trials from University of Florida

Amendment history

2026-09-11
Study Status v18
Primary completion pushed: 2027-09-15 → 2028-09-15
Completion pushed: 2027-09-15 → 2028-09-15
Start date2026-09-15→2027-09-15
2025-08-14
Study Status v17
Re-verified, no change to tracked fields
2024-07-15
Study Status v16
Primary completion date2025-09-15→2027-09-15
Completion date2026-09-15→2027-09-15
Start date2024-09-15→2026-09-15
2023-06-23
Study Status v15
Primary completion date2022-01→2025-09-15
Completion date2022-01→2026-09-15
Start date2021-10→2024-09-15
2021-05-05
Study Status v14
Start date2021-06→2021-10
Show 13 earlier versions
2020-12-01
Study Status, Contacts/Locations v13
Re-verified, no change to tracked fields
2020-12-01
Study Status, Contacts/Locations v12
Start date2020-09→2021-06
2020-03-23
Study Status v11
Primary completion date2020-10→2022-01
Completion date2020-11→2022-01
Start date2020-02→2020-09
2019-11-08
Study Status v10
Start date2019-11→2020-02
2019-08-09
Study Status v9
Start date2019-07→2019-11
2019-05-22
Study Status v8
Re-verified, no change to tracked fields
2019-03-27
Study Status v7
Start date2019-03→2019-07
2019-02-01
Study Identification, Study Status, Sponsor/Collaborators v6
Collaborators1 to 2 entries
Patient-Centered Outcomes Research Institute
2019-01-11
Study Identification, Study Status v5
Re-verified, no change to tracked fields
2018-12-27
Study Status v4
Start date2019-01→2019-03
2018-06-04
Study Status v3
Primary completion date2018-10→2020-10
Completion date2018-11→2020-11
Start date2018-05→2019-01
2018-04-09
Study Status v2
Start date2018-04→2018-05
2018-02-09
Study Status, Document Section v1
Re-verified, no change to tracked fields
2018-02-05
Original filing
Human papillomavirus (HPV) vaccines have potential to prevent an average of 26,900 cancer cases each year in the United States, but vaccine coverage rates remain low. The study team has developed an electronic application (app), Protect Me 4, to help parents and providers assess and have more productive conversations about needed vaccines. The specific aims of this study are to: (1) evaluate the feasibility of implementing Protect Me 4, and (2) estimate preliminary efficacy of Protect Me 4 to increase HPV vaccine initiation (receipt of first dose).
Trial Details
NCT Number NCT03429413
Lead Sponsor University of Florida
Collaborators: National Cancer Institute (NCI), Patient-Centered Outcomes Research Institute
Conditions Human Papillomavirus (HPV) Vaccines
Enrollment 1,296 participants
Start Date 2027-09-15
Primary Completion 2028-09-15 (estimated)
Study Completion 2028-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-09-14